Cargando…

Polish Validation of the SarQoL(®), a Quality of Life Questionnaire Specific to Sarcopenia

Recently, SarQoL(®) (Sarcopenia and Quality of Life), a quality of life (QoL) questionnaire specific to sarcopenia, was successfully developed. For practical reasons, there is a great interest in validating this questionnaire in other populations. The aim of this cross-sectional study was to transla...

Descripción completa

Detalles Bibliográficos
Autores principales: Konstantynowicz, Jerzy, Abramowicz, Pawel, Glinkowski, Wojciech, Taranta, Ewa, Marcinowicz, Ludmila, Dymitrowicz, Malgorzata, Reginster, Jean-Yves, Bruyere, Olivier, Beaudart, Charlotte
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6210457/
https://www.ncbi.nlm.nih.gov/pubmed/30287728
http://dx.doi.org/10.3390/jcm7100323
_version_ 1783367119181709312
author Konstantynowicz, Jerzy
Abramowicz, Pawel
Glinkowski, Wojciech
Taranta, Ewa
Marcinowicz, Ludmila
Dymitrowicz, Malgorzata
Reginster, Jean-Yves
Bruyere, Olivier
Beaudart, Charlotte
author_facet Konstantynowicz, Jerzy
Abramowicz, Pawel
Glinkowski, Wojciech
Taranta, Ewa
Marcinowicz, Ludmila
Dymitrowicz, Malgorzata
Reginster, Jean-Yves
Bruyere, Olivier
Beaudart, Charlotte
author_sort Konstantynowicz, Jerzy
collection PubMed
description Recently, SarQoL(®) (Sarcopenia and Quality of Life), a quality of life (QoL) questionnaire specific to sarcopenia, was successfully developed. For practical reasons, there is a great interest in validating this questionnaire in other populations. The aim of this cross-sectional study was to translate and adjust the SarQoL(®) into Polish and to standardize the validity of this method for the assessment of sarcopenic individuals in Poland with regard to psychometric properties. The English version was used for the translation process. A total of 106 community-dwelling Caucasian subjects aged 73.3 ± 5.94 years (65.1% females) were studied, with 60 participants being diagnosed sarcopenic. The translation and cross-cultural adaptation was carried out in five phases according to specific standard guidelines. There were no major linguistic issues in the translation process. The data confirmed a good discriminant validity, i.e., significantly lower scores for all domains (reduced global QoL in sarcopenic subjects compared to non-sarcopenic ones; 54.9 ± 16.5 vs. 63.3 ± 17.1, p = 0.013), and high internal consistency (Cronbach’s alpha coefficient was 0.92). The significant correlation of the SarQoL(®) scores with those of other questionnaires (SF-36v2(®) Health Survey and EuroQoL-5-Dimension) that are supposed to have similar dimensions indicated the consistent construct validity of the SarQoL(®)-PL questionnaire. No floor/ceiling effects were found. An excellent agreement was found between the test and the re-test (intraclass coefficient correlation (ICC): 0.99). The first Polish version of the SarQoL(®) questionnaire is valid and consistent and therefore may be used with reliability for clinical and research purposes regarding QoL assessment of sarcopenic individuals. However, further research, in particular prospective studies, is needed to determine potential limitations and the suitability of the new tool for the Polish scenario and specificity.
format Online
Article
Text
id pubmed-6210457
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-62104572018-11-02 Polish Validation of the SarQoL(®), a Quality of Life Questionnaire Specific to Sarcopenia Konstantynowicz, Jerzy Abramowicz, Pawel Glinkowski, Wojciech Taranta, Ewa Marcinowicz, Ludmila Dymitrowicz, Malgorzata Reginster, Jean-Yves Bruyere, Olivier Beaudart, Charlotte J Clin Med Article Recently, SarQoL(®) (Sarcopenia and Quality of Life), a quality of life (QoL) questionnaire specific to sarcopenia, was successfully developed. For practical reasons, there is a great interest in validating this questionnaire in other populations. The aim of this cross-sectional study was to translate and adjust the SarQoL(®) into Polish and to standardize the validity of this method for the assessment of sarcopenic individuals in Poland with regard to psychometric properties. The English version was used for the translation process. A total of 106 community-dwelling Caucasian subjects aged 73.3 ± 5.94 years (65.1% females) were studied, with 60 participants being diagnosed sarcopenic. The translation and cross-cultural adaptation was carried out in five phases according to specific standard guidelines. There were no major linguistic issues in the translation process. The data confirmed a good discriminant validity, i.e., significantly lower scores for all domains (reduced global QoL in sarcopenic subjects compared to non-sarcopenic ones; 54.9 ± 16.5 vs. 63.3 ± 17.1, p = 0.013), and high internal consistency (Cronbach’s alpha coefficient was 0.92). The significant correlation of the SarQoL(®) scores with those of other questionnaires (SF-36v2(®) Health Survey and EuroQoL-5-Dimension) that are supposed to have similar dimensions indicated the consistent construct validity of the SarQoL(®)-PL questionnaire. No floor/ceiling effects were found. An excellent agreement was found between the test and the re-test (intraclass coefficient correlation (ICC): 0.99). The first Polish version of the SarQoL(®) questionnaire is valid and consistent and therefore may be used with reliability for clinical and research purposes regarding QoL assessment of sarcopenic individuals. However, further research, in particular prospective studies, is needed to determine potential limitations and the suitability of the new tool for the Polish scenario and specificity. MDPI 2018-10-04 /pmc/articles/PMC6210457/ /pubmed/30287728 http://dx.doi.org/10.3390/jcm7100323 Text en © 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Konstantynowicz, Jerzy
Abramowicz, Pawel
Glinkowski, Wojciech
Taranta, Ewa
Marcinowicz, Ludmila
Dymitrowicz, Malgorzata
Reginster, Jean-Yves
Bruyere, Olivier
Beaudart, Charlotte
Polish Validation of the SarQoL(®), a Quality of Life Questionnaire Specific to Sarcopenia
title Polish Validation of the SarQoL(®), a Quality of Life Questionnaire Specific to Sarcopenia
title_full Polish Validation of the SarQoL(®), a Quality of Life Questionnaire Specific to Sarcopenia
title_fullStr Polish Validation of the SarQoL(®), a Quality of Life Questionnaire Specific to Sarcopenia
title_full_unstemmed Polish Validation of the SarQoL(®), a Quality of Life Questionnaire Specific to Sarcopenia
title_short Polish Validation of the SarQoL(®), a Quality of Life Questionnaire Specific to Sarcopenia
title_sort polish validation of the sarqol(®), a quality of life questionnaire specific to sarcopenia
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6210457/
https://www.ncbi.nlm.nih.gov/pubmed/30287728
http://dx.doi.org/10.3390/jcm7100323
work_keys_str_mv AT konstantynowiczjerzy polishvalidationofthesarqolaqualityoflifequestionnairespecifictosarcopenia
AT abramowiczpawel polishvalidationofthesarqolaqualityoflifequestionnairespecifictosarcopenia
AT glinkowskiwojciech polishvalidationofthesarqolaqualityoflifequestionnairespecifictosarcopenia
AT tarantaewa polishvalidationofthesarqolaqualityoflifequestionnairespecifictosarcopenia
AT marcinowiczludmila polishvalidationofthesarqolaqualityoflifequestionnairespecifictosarcopenia
AT dymitrowiczmalgorzata polishvalidationofthesarqolaqualityoflifequestionnairespecifictosarcopenia
AT reginsterjeanyves polishvalidationofthesarqolaqualityoflifequestionnairespecifictosarcopenia
AT bruyereolivier polishvalidationofthesarqolaqualityoflifequestionnairespecifictosarcopenia
AT beaudartcharlotte polishvalidationofthesarqolaqualityoflifequestionnairespecifictosarcopenia